Floatz logo

Cyclophosphamide

Cervical Carcinoma

City of Hope Medical CenterSmall moleculePhase 2Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

47 Active assets in the Cervical Carcinoma cohort.

Asset / SponsorPhaseRating
Epirubicin
Mayo Clinic
Phase 2BB
Hycamtin
Advenchen Laboratories, LLC
Phase 3BB
Pembrolizumab
Mayo Clinic
Phase 2BB
Inno-206
Advenchen Laboratories, LLC
Phase 3B
Nivolumab
Fred Hutchinson Cancer Center
Phase 2B

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →